Thomas Tousseyn
Thomas Tousseyn
Adjunct-Kliniekhoofd Pathologische Ontleedkunde UZ Leuven; Deeltijds Hoofddocent Faculteit
Email confirmado em
Citado por
Citado por
ADAM10 cleavage of N‐cadherin and regulation of cell–cell adhesion and β‐catenin nuclear signalling
K Reiss, T Maretzky, A Ludwig, T Tousseyn, B De Strooper, D Hartmann, ...
The EMBO journal 24 (4), 742-752, 2005
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma
R Crescenzo, F Abate, E Lasorsa, M Gaudiano, N Chiesa, F Di Giacomo, ...
Cancer cell 27 (4), 516-532, 2015
Differential contribution of the three Aph1 genes to γ-secretase activity in vivo
L Serneels, T Dejaegere, K Craessaerts, K Horré, E Jorissen, T Tousseyn, ...
Proceedings of the National Academy of Sciences 102 (5), 1719-1724, 2005
ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the γ-secretase
T Tousseyn, A Thathiah, E Jorissen, T Raemaekers, U Konietzko, K Reiss, ...
Journal of Biological Chemistry 284 (17), 11738-11747, 2009
Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 …
J Morscio, D Dierickx, J Nijs, G Verhoef, E Bittoun, X Vanoeteren, ...
The American Journal of Surgical Pathology 38 (7), 875-886, 2014
Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing
F Amant, M Verheecke, I Wlodarska, L Dehaspe, P Brady, N Brison, ...
JAMA oncology 1 (6), 814-819, 2015
Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development
X Sagaert, E Van Cutsem, G De Hertogh, K Geboes, T Tousseyn
Nature reviews Gastroenterology & hepatology 7 (6), 336, 2010
How I treat posttransplant lymphoproliferative disorders
D Dierickx, T Tousseyn, O Gheysens
Blood, The Journal of the American Society of Hematology 126 (20), 2274-2283, 2015
JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma
K Van Roosbroeck, L Cox, T Tousseyn, I Lahortiga, O Gielen, B Cauwelier, ...
Blood, The Journal of the American Society of Hematology 117 (15), 4056-4064, 2011
Histological transformation and progression in follicular lymphoma: a clonal evolution study
R Kridel, FC Chan, A Mottok, M Boyle, P Farinha, K Tan, B Meissner, ...
PLoS medicine 13 (12), e1002197, 2016
JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model
S Degryse, CE De Bock, L Cox, S Demeyer, O Gielen, N Mentens, ...
Blood, The Journal of the American Society of Hematology 124 (20), 3092-3100, 2014
Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or R-CHOP …
RU Trappe, D Dierickx, H Zimmermann, F Morschhauser, P Mollee, ...
Journal of Clinical Oncology 35 (5), 536-543, 2017
Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ
K Put, A Avau, E Brisse, T Mitera, S Put, P Proost, B Bader-Meunier, ...
Rheumatology 54 (8), 1507-1517, 2015
Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a …
P Vandenberghe, I Wlodarska, T Tousseyn, L Dehaspe, D Dierickx, ...
The Lancet Haematology 2 (2), e55-e65, 2015
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma
M Boi, A Rinaldi, I Kwee, P Bonetti, M Todaro, F Tabbò, R Piva, ...
Blood 122 (15), 2683-2693, 2013
Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma-endpoints of a spectrum of one disease?
S Hartmann, C Döring, C Jakobus, B Rengstl, S Newrzela, T Tousseyn, ...
PloS one 8 (11), e78812, 2013
Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors
D Dierickx, T Tousseyn, X Sagaert, S Fieuws, I Wlodarska, J Morscio, ...
Leukemia & lymphoma 54 (11), 2433-2440, 2013
Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?
J Morscio, D Dierickx, T Tousseyn
Clinical and Developmental Immunology 2013, 2013
Gene expression profiling reveals clear differences between EBV‐positive and EBV‐negative posttransplant lymphoproliferative disorders
J Morscio, D Dierickx, JF Ferreiro, A Herreman, P Van Loo, E Bittoun, ...
American Journal of Transplantation 13 (5), 1305-1316, 2013
Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching
L De Smedt, S Palmans, D Andel, O Govaere, B Boeckx, D Smeets, ...
British journal of cancer 116 (1), 58-65, 2017
O sistema não pode efectuar a operação agora. Tente novamente mais tarde.
Artigos 1–20